Arbutus Biopharma Corp
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-84.4M | $-384.2M | $-62.7M | $-38.8M | $-14.1M | $29.6M | $-10.1M |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | $2.0M | $1.1M | $589.0K | $529.0K | $613.0K | $866.0K | $986.9K |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $15.1M | — | — | — | $903.0K | $982.3K | $633.4K |
| Net Cash from Operating Activities | $-48.6M | $-57.9M | $-56.4M | $-12.4M | $-6.7M | $32.9M | $-7.8M |
| Investing Activities | |||||||
| Capital Expenditures | $7.3M | $4.0M | $2.3M | $1.1M | $725.0K | $15.0K | $60.4K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $27.8M | $-99.1M | $7.7M | $-43.0M | $-725.0K | $-12.0K | $-60.4K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $49.3M | $12.6M | $143.9M | $60.7M | $32.7M | $4.5M | $4.6M |
| Net Change in Cash | $30.9M | $-143.4M | $94.6M | $3.5M | $21.7M | $38.0M | $-3.4M |
| Free Cash Flow | $-55.9M | $-61.9M | $-58.7M | $-13.5M | $-7.5M | $32.9M | $-7.9M |